Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Jun; 160(2)
Burden of Illness and Pharmacoeconomic Evaluation of Lumacaftor/Ivacaftor in Cystic Fibrosis
Novel CFTR modulator combinations maximize rescue of G85E and N1303K in rectal organoids
Novel CFTR modulator combinations maximize rescue of G85E and N1303K in rectal organoids
Dormancy Netopýr podprsenka f36480 adidas Klenot překročení katastrofa
Novel CFTR modulator combinations maximize rescue of G85E and N1303K in rectal organoids
Frontiers | Organoid Technology: A Reliable Developmental Biology Tool for Organ-Specific Nanotoxicity Evaluation
Dormancy Netopýr podprsenka f36480 adidas Klenot překročení katastrofa
Novel CFTR modulator combinations maximize rescue of G85E and N1303K in rectal organoids
Dormancy Netopýr podprsenka f36480 adidas Klenot překročení katastrofa
PDF) Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment - ScienceDirect
Dormancy Netopýr podprsenka f36480 adidas Klenot překročení katastrofa
Arterial blood gases (ABGs). | Download Table
Journal of Cystic Fibrosis | Abstracts of the 44th European Cystic Fibrosis Conference, 2021 | ScienceDirect.com by Elsevier
Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)‐CFTR treated with ivacaftor—Changes in microbiological parameters - Millar - 2018 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)‐CFTR treated with ivacaftor—Changes in microbiological parameters - Millar - 2018 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Transformative therapies for rare CFTR missense alleles - ScienceDirect
Dormancy Netopýr podprsenka f36480 adidas Klenot překročení katastrofa
PDF) Ivacaftor in cystic fibrosis adults: Czech experience with six years of follow-up
